Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461615 · ClinicalTrials.gov registry record
A National Registry For Pulmonary Alveolar Proteinosis
A clinical trial of Pulmonary Alveolar Proteinosis, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT02461615: Recruiting study of Pulmonary Alveolar Proteinosis, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02461615 is a study of Pulmonary Alveolar Proteinosis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02461615, a study of Pulmonary Alveolar Proteinosis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The major goal of Part A of this study is to establish a National PAP Registry to help make reliable new research tests available to doctors to improve the diagnosis of PAP, increase awareness and knowledge of PAP, and give patients a 'seat at the table' in planning and conducting PAP research including the clinical testing of several new potential therapies. The major goal of Part B of this study is to define the natural history of autoimmune PAP (aPAP), develop a disease severity score that reflects how aPAP patients feel and function, and to develop and test novel tools to measure the severity of aPAP lung disease. Funding Source - FDA OOPD
Primary Outcome
GM-CSF antibody measurement from a diagnostic blood spot (DBS) card to diagnose autoimmune PAP among participants with PAP of any type
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2015-04 |
| Est. Completion | 2030-12 |
What NCT02461615 shows while recruiting
NCT02461615 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pulmonary Alveolar Proteinosis appearing as the primary indexed condition, and to 0 interventions.
NCT02461615 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02461615 about?
NCT02461615 is a clinical study titled "A National Registry For Pulmonary Alveolar Proteinosis". The major goal of Part A of this study is to establish a National PAP Registry to help make reliable new research tests available to doctors to improve the diagnosis of PAP, increase awareness and knowledge of PAP, and give patients a 'seat at the table' in planning and conducting PAP research inclu...
What is the current status of trial NCT02461615?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2015-04. Estimated completion is 2030-12.
What conditions does trial NCT02461615 study?
This clinical trial studies the following conditions: Pulmonary Alveolar Proteinosis.
Who is sponsoring clinical trial NCT02461615?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02461615 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Alveolar Proteinosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia